The loss of muscle mass and sarcopenia: Non hormonal intervention

被引:18
|
作者
Sanchis-Gomar, Fabian [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Vina, Jose [1 ]
机构
[1] Univ Valencia, Dept Physiol, Fac Med, Fdn Invest Hosp Clin Univ INCLIVA, Valencia 46010, Spain
关键词
Aging; Life span; Muscle atrophy; Immobilization; Hormonal treatments; SKELETAL-MUSCLE; RESISTANCE EXERCISE; OLDER-ADULTS; COACTIVATOR; STRENGTH; METAANALYSIS; PGC-1-ALPHA; ATROPHY; DAMAGE; MICE;
D O I
10.1016/j.exger.2011.08.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Muscle aging is a key component of the increase in frailty in human populations. The generation of critical levels of power is a prerequisite to perform simple tasks of daily living, such as rising from a chair or climbing stairs. There is great scientific and social interest to determine which behaviors can lead to the maintenance of the muscle mass in young immobilized subjects and in the elderly. Several hormonal treatments have been proposed for the treatment of sarcopenia. However, the side effects associated to these treatments emphasize the need of finding non-toxic and non-hormonal treatments that help increase muscle strength, improve muscle function, and decrease the degree of dependency in the old population. Recently, several studies have shed new light on this topic. Any medical efforts to develop treatments to prevent muscle dysfunction leading to sarcopenia, and eventually frailty, will be a major breakthrough in the public health in advances countries. Moreover, any significant improvement in the loss of muscle function will be a major breakthrough in the health and welfare of the population. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:967 / 969
页数:3
相关论文
共 50 条
  • [1] Inflammatory markers and loss of muscle mass (sarcopenia) and strength
    Schaap, Laura A.
    Pluijm, Saskia M. F.
    Deeg, Dorly J. H.
    Visser, Marjolein
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (06): : 526.e9 - 526.e17
  • [2] Editor's choice: sarcopenia or loss of muscle mass
    Walker, Richard F.
    CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 139 - 141
  • [3] Sarcopenia: Molecular regulatory network for loss of muscle mass and function
    Wu, Jiaxiang
    Ding, Ping'an
    Wu, Haotian
    Yang, Peigang
    Guo, Honghai
    Tian, Yuan
    Meng, Lingjiao
    Zhao, Qun
    FRONTIERS IN NUTRITION, 2023, 10
  • [4] Prediabetes is associated with loss of appendicular skeletal muscle mass and sarcopenia
    Li, Shuying
    Mao, Jiangfeng
    Zhou, Weihong
    FRONTIERS IN NUTRITION, 2023, 10
  • [5] SARCOPENIA: AGING-RELATED LOSS OF MUSCLE MASS AND FUNCTION
    Larsson, Lars
    Degens, Hans
    Li, Meishan
    Salviati, Leonardo
    Lee, Young Il
    Thompson, Wesley
    Kirkland, James L.
    Sandri, Marco
    PHYSIOLOGICAL REVIEWS, 2019, 99 (01) : 427 - 511
  • [6] Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis
    Bennett, Joshua. L. L.
    Pratt, Arthur. G. G.
    Dodds, Richard
    Sayer, Avan. A. A.
    Isaacs, John. D. D.
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (04) : 239 - 251
  • [7] Functional Deficits Precede Muscle Mass Loss: Implications for Sarcopenia Diagnosis
    Hayes, Alan
    McMillan, Lachlan B.
    Goodman, Craig A.
    Scott, David
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2016, 48 (05): : 354 - 354
  • [8] Prediction of Loss of Muscle Mass in Sarcopenia Using Ultrasonic Diaphragm Excursion
    Zeng, Bin
    He, Shaochong
    Lu, Hao
    Liang, Guiyin
    Ben, Xiaosong
    Zhong, Wenzhao
    Zhang, Mingsheng
    Wang, Hao
    CONTRAST MEDIA & MOLECULAR IMAGING, 2021, 2021
  • [9] Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis
    Joshua L. Bennett
    Arthur G. Pratt
    Richard Dodds
    Avan A. Sayer
    John D. Isaacs
    Nature Reviews Rheumatology, 2023, 19 : 239 - 251
  • [10] Sarcopenia ≠ low muscle mass
    Cruz-Jentoft, Alfonso J.
    Gonzalez, M. Cristina
    Prado, Carla M.
    EUROPEAN GERIATRIC MEDICINE, 2023, 14 (02) : 225 - 228